Diagnosis and treatment of cerebral amyloid angiopathy

E Feldmann1, J Tornabene

  • 1Department of Clinical Neurosciences, Brown University, Providence, Rhode Island.

Insights

Cerebral amyloid angiopathy (CAA) involves amyloid buildup in brain vessels, leading to lobar hemorrhages. Diagnosis requires brain biopsy, and management focuses on blood pressure control, avoiding blood thinners.

Area of Science:

  • Neurology
  • Pathology
  • Vascular Biology

Background:

  • Cerebral amyloid angiopathy (CAA) is characterized by amyloid deposition in leptomeningeal and cortical vessels.
  • It predominantly affects individuals over 60 and is linked to lobar intracerebral hemorrhage, normal aging, Alzheimer's disease, and other cerebrovascular conditions.
  • The amyloid deposits in CAA share biochemical similarities with those found in Alzheimer's disease and normal aging.

Purpose of the Study:

  • To elucidate the characteristics and clinical manifestations of cerebral amyloid angiopathy (CAA).
  • To understand the association of CAA with intracerebral hemorrhage and dementia.
  • To outline diagnostic and management strategies for CAA.

Main Methods:

  • Review of existing literature on CAA, focusing on its pathology, clinical presentation, and associations.
  • Analysis of biochemical studies comparing amyloid deposits in various neurological conditions.
  • Discussion of diagnostic methods, including brain biopsy, and current management approaches for CAA-associated hemorrhage.

Main Results:

  • CAA primarily manifests as lobar intracerebral hemorrhage, increasing in frequency with age.
  • Identical amyloid deposits are observed in CAA, normal aging, Alzheimer's disease, and hereditary cerebral hemorrhage.
  • The precise mechanisms linking CAA to hemorrhage and dementia remain incompletely understood.

Conclusions:

  • Cerebral amyloid angiopathy is a significant cause of lobar hemorrhage in the elderly.
  • Definitive diagnosis of CAA necessitates a brain biopsy.
  • Management emphasizes hypertension control and supportive care, with avoidance of antiplatelet/anticoagulant therapies in affected patients.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...